What is new in the management of rapidly progressive glomerulonephritis? - Test2 - elhamkhani - TriplyDB

What is new in the management of rapidly progressive glomerulonephritis?

What is new in the management of rapidly progressive glomerulonephritis?

http://www.wikidata.org/entity/Q28259540

about

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis.Anti-glomerular basement membrane glomerulonephritis following nintedanib for idiopathic pulmonary fibrosis: a case report.Therapeutic Apheresis in Immunologic Renal and Neurological Diseases.Diagnostic dilemmas in a girl with acute glomerulonephritis: Answers.Assessment of the etiologies and renal outcomes of rapidly progressive glomerulonephritis in pediatric patients at King Abdulaziz University Hospital, Jeddah, Saudi Arabia.Renal outcome and risk factors for end-stage renal disease in pediatric rapidly progressive glomerulonephritis.Staphylococcus-Associated Glomerulonephritis Mimicking Henoch-Schönlein Purpura and Cryoglobulinemic Vasculitis in a Patient With an Epidural Abscess: A Case Report and Brief Review of the Literature.

P2860

Q30276550-8C31792A-36D6-4988-95A8-9B331A02E539 Q33793476-83C860C2-14A1-4123-9A43-5785E7045B43 Q38639201-664EFF23-72E6-427E-86F7-2067A2B38754 Q39025553-ABA70692-C845-4A07-84D0-6E701AD82912 Q40299730-CE32C66E-0A76-4CCD-B000-9BA4305379B1 Q54241537-AF0AF792-A212-451F-8F9B-51C707DE651C Q54536081-4C528D01-7F00-4D33-A323-F076A3A5F47E Q55105658-247BA9EE-DD16-4111-95D9-28C3AB840DEB

P2860

What is new in the management of rapidly progressive glomerulonephritis?

http://www.wikidata.org/entity/Q28259540

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

What is new in the management of rapidly progressive glomerulonephritis?

@ast

What is new in the management of rapidly progressive glomerulonephritis?

@en

What is new in the management of rapidly progressive glomerulonephritis?

@nl

type

label

What is new in the management of rapidly progressive glomerulonephritis?

@ast

What is new in the management of rapidly progressive glomerulonephritis?

@en

What is new in the management of rapidly progressive glomerulonephritis?

@nl

prefLabel

What is new in the management of rapidly progressive glomerulonephritis?

@ast

What is new in the management of rapidly progressive glomerulonephritis?

@en

What is new in the management of rapidly progressive glomerulonephritis?

@nl

P1433

Q28259540-03744F9F-F7DE-4E4D-9A9D-473162564157

P1476

Q28259540-AF7EBAF8-50A9-4F14-9A8B-906B80577FB2

P2093

Q28259540-3CF199A9-1AD1-4CCE-A9AB-A1316A8A2F47

Q28259540-BE75E3F8-DEED-442E-8833-8B6B67DC0F37

P2860

Q28259540-013D952D-0077-4B4D-B8B5-4F1AEE5261AD

Q28259540-04BA9F00-9729-47B1-A0A1-966553E54D1A

Q28259540-08182925-FCF6-4A59-A276-22C2848C2813

Q28259540-0A80C5E1-5423-4093-9035-0CA16B3386AD

Q28259540-0F8077B8-8B62-4D2D-939E-4E74969A203A

Q28259540-13673197-A128-41A2-B1F6-5BBDA585C1B5

Q28259540-18BED8DF-C74B-4F10-A807-B9CB9147111C

Q28259540-1FD86E0A-2EE1-4B49-AA34-8C443115852F

Q28259540-238570FD-3031-48E3-8546-6B1608E53CF6

Q28259540-25723449-175B-4043-9F8F-F5786B9EBC41

P304

Q28259540-BEEEEC51-629E-4F3D-9D04-B4D896B3041A

P31

Q28259540-9A1EE1AE-3477-4D97-B54F-6150CFE7C610

P356

Q28259540-373E1A5C-CED0-46A0-BEE8-B98E38BEE459

P407

Q28259540-9E96309C-225E-4017-9BAE-388A578C308A

P433

Q28259540-DFF3D944-F5AF-447B-9D08-30873AE5309F

P478

Q28259540-B808D7EA-7631-430A-91BB-2734E73C8F3B

P577

Q28259540-43D49D53-0E49-4480-A41D-E62F8937636B

P5875

Q28259540-20E85CCE-D1E0-494C-8E3C-7870433E280F

P698

Q28259540-5F0E3576-65E4-478D-8874-ED8DB9C79623

P921

Q28259540-0F4D1A94-995B-4074-B14D-412DEFFF69D1

Q28259540-3C7F0022-F713-45E6-A12B-6E9C7C49F0C3

P932

Q28259540-AB1E5326-B60E-454C-AF56-04178D9FFA01

P356

P1433

Clinical kidney journal / an academic journal of the ERA-EDTA (European Renal Association - European Dialysis and Transplant Association)

P1476

What is new in the management of rapidly progressive glomerulonephritis?

@en

P2093

Alan D Salama

http://www.w3.org/2001/XMLSchema#string

George H B Greenhall

http://www.w3.org/2001/XMLSchema#string

P2860

Epidermal growth factor: a new therapeutic target in glomerular disease.

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.

Glutathione S-transferase Mu 2-transduced mesenchymal stem cells ameliorated anti-glomerular basement membrane antibody-induced glomerulonephritis by inhibiting oxidation and inflammation

Stem cell-based cell therapy for glomerulonephritis

Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.

Long-term outcome of anti-glomerular basement membrane antibody disease treated with immunoadsorption.

Etanercept plus standard therapy for Wegener's granulomatosis.

Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis.

P304

143-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CKJ/SFV008

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273526949

http://www.w3.org/2001/XMLSchema#string

P698

25815169

http://www.w3.org/2001/XMLSchema#string

P921

rapidly progressive glomerulonephritis

glomerulonephritis

P932

4370308

http://www.w3.org/2001/XMLSchema#string